Noticias de KPTI_US

Noticias del mercado

Últimas noticias sobre KPTI_US — 136 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: KPTI_US ✕ 136 resultados
24/03/2026 KPTI_US — StockInvest.us
Karyopharm Shares Jump 10% Following Mixed Phase 3 Trial Outcomes on Myelofibrosis Treatment
24/03/2026 KPTI_US — Stock Titan
SENTRY myelofibrosis data and $30M private placement reshape Karyopharm (NASDAQ: KPTI)
24/03/2026 KPTI_US — TradingView
Karyopharm Therapeutics Raises ~$30 Million in RA Capital Private Placement, $44 Million Warrant Upside
24/03/2026 KPTI_US — PR Newswire
Karyopharm Announces $30 Million Private Placement with RA Capital
24/03/2026 KPTI_US — Karyopharm
Karyopharm's Phase 3 SENTRY Trial in Myelofibrosis Met First Co-Primary Endpoint, Demonstrating Statistically Significant Improvement in Spleen Volume Reduction
24/03/2026 KPTI_US — Yahoo Finance
Karyopharm Therapeutics SENTRY Trial Hits Spleen Endpoint, Shows Early Survival Signal in Myelofibrosis
24/03/2026 KPTI_US — Seeking Alpha
Karyopharm posts trial win for Xpovio in myelofibrosis (KPTI)
24/03/2026 KPTI_US — citybiz
Karyopharm Therapeutics Secures $30M Private Placement with RA Capital Management
24/03/2026 KPTI_US — Benzinga
Why Is Karyopharm Therapeutics Stock Trading Lower Today? - Karyopharm Therapeutics (NASDAQ:KPTI)
24/03/2026 KPTI_US — Stock Titan
New myelofibrosis drug combo shrank spleens in half of patients
24/03/2026 KPTI_US — GuruFocus
Karyopharm Therapeutics (KPTI) Secures $30M in Private Placement, Stock Soars
24/03/2026 KPTI_US — Stock Titan
Karyopharm adds $30M cash, warrant upside tied to Phase 3 readout
24/03/2026 KPTI_US — Bitget ES ← EN
Karyopharm anuncia una colocación privada de 30 millones de dólares con RA Capital
24/03/2026 KPTI_US — Investing.com
Karyopharm’s myelofibrosis trial meets one of two primary goals
24/03/2026 KPTI_US — Investing.com
Karyopharm raises $30M in private placement with RA Capital
24/03/2026 KPTI_US — Investing.com
RBC Capital maintains Outperform on Karyopharm stock after trial data
24/03/2026 KPTI_US — TipRanks
Karyopharm Announces Financing and Positive SENTRY Trial Results
24/03/2026 KPTI_US — Investing.com
Karyopharm stock gains 10% on mixed Phase 3 trial data
19/03/2026 KPTI_US — Stock Titan ES ← EN
Presentaciones ante la SEC de KPTI: formularios 10-K, 10-Q, 8-K de Karyopharm Therapeutics Inc
10/03/2026 KPTI_US — GuruFocus ES ← EN
KPTI: Rodman & Renshaw inicia cobertura con una calificación de 'Comprar' |

Página 6 de 7

keyboard_arrow_up